Quantcast
Search Daily Dose & Film Annex
Loading

BIO SmartBrief

Daily Dose Newsletter

Friday
Apr132012

BioSmart Brief: Highlights NeoStem's PreSERVE Trial $NBS

PreSERVE-AMI tests autologous stem cell treatment for heart attack
Doctors at Orlando Health have started a trial as part of the nationwide PreSERVE-AMI study of pelvic bone marrow stem cells in treating tissue damage after a heart attack. The study of autologous transplant will involve 160 patients at 34 sites. American City Business Journals/Orlando, Fla.

PrintView Printer Friendly Version

EmailEmail Article to Friend

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>
« China Cord Blood (NYSE: CO)Gets a $65 million injection - $CO | Main | Pharma's iPad attraction marks tech adoption shift @ Fierce Biotech It »